Chargement en cours...
Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet Syndrome treatment
Dravet syndrome (DS) is a catastrophic pediatric epilepsy with severe intellectual disability, impaired social development and persistent drug-resistant seizures. One of its primary monogenic causes are mutations in Na(v)1.1 (SCN1A), a voltage-gated sodium channel. Here we characterise zebrafish Na(...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891590/ https://ncbi.nlm.nih.gov/pubmed/24002024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms3410 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|